[Antiviral activity of anomeric 5-substituted 2'-deoxyuridines]. 1979

T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova

The inhibiting effect for herpes and vaccinia viruses of 2'-deoxyuridine derivatives containing the substitute in the position of 5-pyrimidine ring was studied. Anomeric 5-isopropyl-2'-deoxyuridines were shown to produce a marked inhibiting effect in chick embryo fibroblasts infected with herpes virus and to have no effect on vaccinia virus replication, that is, to be specific antiherpetic agents. The alpha-anomer of 5-isopropyl-2'-deoxyuridine showed antiherpetic activity in vitro comparable with that of beta-anomer. Fifty per cent toxic doses and chemotherapeutic indices of the drugs under study were determined in comparison with those of 5-iod-2'-deoxyuridine.

UI MeSH Term Description Entries
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D003857 Deoxyuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. (beta 1-(2-Deoxyribopyranosyl))thymidine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006564 Herpesviridae A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. Mouse Thymic Virus,Murid herpesvirus 3,Thymic Group Viruses,Herpesviruses,Mouse Thymic Viruses,Thymic Virus, Mouse,Thymic Viruses, Mouse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D014616 Vaccinia virus The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS. Buffalopox virus,Poxvirus officinale,Rabbitpox virus,Buffalo Pox Virus,Rabbit Pox Virus,Buffalo Pox Viruses,Buffalopox viruses,Rabbit Pox Viruses,Rabbitpox viruses,Vaccinia viruses,Virus, Buffalo Pox,Viruses, Buffalo Pox,virus, Buffalopox

Related Publications

T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
June 1991, Journal of medicinal chemistry,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
November 1979, Biochemical pharmacology,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
July 1964, Journal of medicinal chemistry,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
October 1980, Methods and findings in experimental and clinical pharmacology,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
September 1988, Journal of medicinal chemistry,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
March 1983, Antimicrobial agents and chemotherapy,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
September 1985, Bioorganicheskaia khimiia,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
May 1986, Journal of medicinal chemistry,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
July 1976, Journal of medicinal chemistry,
T A Bektemirov, and E V Chekunova, and O G Andzhaparidze, and S Ia Mel'nik, and A A Bakhmedova
July 1987, Bioorganicheskaia khimiia,
Copied contents to your clipboard!